“A mix-up of boxes in the printing house that produced them and insufficient control actions were identified as the reason behind the error,” it said, citing the results of an in-house probe at Santonika, the manufacturer of the medications.
The agency itself carried out two unscheduled inspections of Santonika in July and August.
The first inspection revealed “a lack of control during the production process” and the second one was conducted to see if the company had eliminated the shortcomings.
Santonika has carried out an audit of the printing house and recommended that it step up error prevention. It has also tightened its own quality control procedures.
Almost 2,000 packages of morphine produced by Santonika were withdrawn from the market in late July after it was established that morphine ampoules had been put into packages labelled as atropine sulfate.
This was the first such incident ever reported in Lithuania.
Kęstutis Budrys, the President's Senior Adviser, who has been nominated for the post of Minister…
In the heart of Bulgaria, the city of Plovdiv reveals a rich tapestry of ancient…
"We can shout very loudly, but it won't change the position of the American people,"…
From mocking messages flooding social networks to harsh criticism from political experts, the decision of…
Republic Day has been celebrated in Kazakhstan as the main national date since 2022, giving…
According to Lrytas.lt, the North Atlantic Treaty Organisation (NATO) faces a new geopolitical reality with…